Fadraciclib is an oral and intravenous CDK (cyclin-dependent kinase) inhibitor being studied for use in several different cancers.
| SparkCures ID | 546 |
|---|---|
| Generic Name | Fadraciclib |
| Treatment Classifications |
There are no resources, links or videos to display for this treatment.